Manipulation of brain DNA synthesis is achieved by using a systemic immunological disease.
Open Access
- 1 August 1982
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 79 (15) , 4783-4785
- https://doi.org/10.1073/pnas.79.15.4783
Abstract
Subsequent to successful immunotherapy, there was a reversal of the deleterious grarf vs. host disease-induced alterations in DNA synthesis in individual cerebellar germinal cells. Immunotherapy involved treating diseased rats on postnatal days 11, 12 and 13 with alloantiserum specifically directed against the grafted lymph node cells injected on the day of birth. On postnatal day 14, diseased, serum-treated, and control littermates were injected with [3H]thymidine and, 15 min later, the cerebella were excised and autoradiographed. A 0.72-mm segment of the external granular layer in the cerebellar fissure between lobules VIB and C was searched for labeled cells. The control group had the greatest number of labeled cells, defined by the presence of 6 or more autoradiographic grains, (43 .+-. 4, mean .+-. SEM [standard error of the mean]) and the greatest number of grains per cell (9.5 .+-. 0.2). Rats with the disease had few labeled cells (4 .+-. 2) and the number of grains per cell was low (6.6 .+-. 0.6); serum treatment increased both the number of labeled cells (26 .+-. 8) and the number of grains per cell (7.4 .+-. 0.2). Without mononuclear infiltrates or inflammation in the cerebellum, a systemic immunological disease can dramatically decrease DNA synthesis per germinal cell and halting the disease by alloantiserum therapy can reverse this effect. The findings emphasize the sensitive plastic nature of neuronal cell acquisition in the normally developing brain.Keywords
This publication has 12 references indexed in Scilit:
- Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.The Journal of Experimental Medicine, 1981
- Graft-versus-host disease impairs cerebellar growthNature, 1978
- MALNUTRITION AND BRAIN DEVELOPMENT: CEREBELLAR WEIGHT, DNA, RNA, PROTEIN AND HISTOLOGICAL CORRELATIONSJournal of Neurochemistry, 1977
- Graft-versus-Host-Reactions: A ReviewPublished by Elsevier ,1976
- CEREBELLAR DEVELOPMENT IN THE RAT AFTER EARLY POSTNATAL DAMAGE BY METHYLAZOXY-METHANOL: DNA, RNA AND PROTEIN DURING RECOVERYJournal of Neurochemistry, 1973
- Experimental reorganization of the cerebellar cortex. I. Morphological effects of elimination of all microneurons with prolonged x‐irradiation started at birthJournal of Comparative Neurology, 1972
- Possible Graft-versus-Host Reaction after Intrauterine Transfusion for Rh Erythroblastosis FetalisNew England Journal of Medicine, 1969
- Hereditary Thymic Dysplasia: A Graft-Versus-Host Reaction Induced by Bone Marrow Cells with a Partial 4a Series HistoincompatibilityPediatric Research, 1969
- XX/XY LYMPHOID CHIMÆRISM IN CONGENITAL IMMUNOLOGICAL DEFICIENCY SYNDROME WITH THYMIC ALYMPHOPLASIAThe Lancet, 1965
- Aplastic Anemia, Histiocytosis and Erythrodermia in Immunologically Deficient ChildrenNew England Journal of Medicine, 1965